Roscovitine-activated HIP2 kinase induce
✍
Józefa Węsierska-Gądek; M. Lienhard Schmitz; Carmen Ranftler
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 314 KB
## Abstract Human MCF‐7 breast cancer cells are relatively resistant to conventional chemotherapy due to the lack of caspase‐3 activity. We reported recently that roscovitine (ROSC), a potent cyclin‐dependent kinase 2 inhibitor, arrests human MCF‐7 breast cancer cells in the G~2~ phase of the cell